| Income Statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
| total revenue | 506 | 444 | 708 | 632* |
| Cost of goods sold | 237 | 206 | 258 | 241* |
| Gross profit | 269 | 238 | 450 | 391* |
| Selling, general and administrative | 708 | 847 | 743 | 773* |
| Research and development | 79 | 74 | 86 | 73* |
| Total operating costs and expenses | 787 | 921 | 829 | 846* |
| Loss from operations | -518 | -683 | -379 | -455* |
| Other income (expense), net | NaN | -1 | 9 | -74* |
| Interest expense, net | 106 | 101 | 94 | -34* |
| Total other income (expense) | -106 | -102 | -85 | -40* |
| Net loss | -624 | -785 | -464 | -495 |
| Basic EPS | -0.01 | -0.01 | 0 | -0.004 |
| Diluted EPS | -0.01 | -0.01 | 0 | -0.004 |
| Basic Average Shares | 110,833,042 | 111,886,473 | 111,886,473 | 111,875,706 |
| Diluted Average Shares | 110,833,042 | 111,886,473 | 111,886,473 | 111,875,706 |
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)